Gabapentin Titration Schedule for Adults with Normal Renal Function
Start gabapentin at 300 mg on day 1, increase to 600 mg/day (300 mg twice daily) on day 2, then 900 mg/day (300 mg three times daily) on day 3, with subsequent titration by 100-300 mg every 1-7 days as tolerated up to 1800-3600 mg/day in three divided doses. 1
Initial Three-Day Titration
The FDA-approved rapid titration schedule is:
- Day 1: 300 mg once daily
- Day 2: 600 mg/day (300 mg twice daily)
- Day 3: 900 mg/day (300 mg three times daily)
This rapid initiation is well-tolerated and supported by both the FDA label 1 and clinical guidelines 2. Research confirms that starting at 900 mg/day immediately is as safe as slower titration, with only a slightly higher incidence of dizziness 3.
Subsequent Dose Escalation
After reaching 900 mg/day on day 3, continue titrating upward:
- Increase by 100-300 mg every 1-7 days as tolerated 2, 1
- Target dose: 1800 mg/day (600 mg three times daily) - this is the minimum effective dose demonstrated in clinical trials 1, 4
- Maximum dose: 3600 mg/day (1200 mg three times daily) for refractory cases 1
The guideline evidence emphasizes that doses above 1800 mg/day show comparable efficacy, though individual patients may benefit from higher doses 2. Research supports that cumulative response rates increase with each dose escalation, and doses up to 3600 mg/day are well-tolerated 4, 5.
Dosing Schedule Requirements
- Administer three times daily with maximum 12-hour intervals between doses 1
- Can be taken with or without food 1
- Duration of adequate trial: 3-8 weeks for titration plus 2 weeks at maximum tolerated dose 2
Important Caveats
Elderly patients: Consider lower starting doses and slower titration due to age-related decline in renal clearance (from ~225 mL/min in those <30 years to ~125 mL/min in those >70 years) 1. The evidence shows apparent oral clearance decreases significantly with age 1.
Nonlinear pharmacokinetics: Gabapentin has saturable absorption, requiring careful dose titration 2. This differs from pregabalin, which has linear pharmacokinetics and more straightforward dosing.
Common side effects: Dose-dependent dizziness and sedation are most common but typically resolve within 10 days 4. These can be minimized by the gradual titration approach.
Discontinuation: Taper gradually over minimum 1 week when stopping or switching medications 1.